REL-ETHYL (.ALPHA.R,.BETA.S)-.ALPHA.-(4-METHOXYBENZOYL)-.BETA.-(NITROMETHYL)-1,3-BENZODIOXOLE-5-PROPANOATE
UNII MJ9DCA8J8C
Substance Identification & Data
This profile provides standardized clinical and technical data for Rel-ethyl (.alpha.r,.beta.s)-.alpha.-(4-methoxybenzoyl)-.beta.-(nitromethyl)-1,3-benzodioxole-5-propanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MJ9DCA8J8C.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 209164-42-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H21NO8 QPSKREVTKUBJMA-VQIMIIECSA-N;QPSKREVTKUBJMA-LPHOPBHVSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Rel-ethyl (.alpha.r,.beta.s)-.alpha.-(4-methoxybenzoyl)-.beta.-(nitromethyl)-1,3-benzodioxole-5-propanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.